Skip to main content

Table 2 Demographics and physical characteristics at baseline

From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Characteristic

Placeboa

Interferon beta 1aa

Pvalue

Age at informed consent (yrs)

64.57 ± 6.4

63.0 ± 9.07

0.57

Height (cm)

165.11 ± 7.52

163.0 ± 9.01

0.42

Weight (kg)

71.59 ± 9.92

68.17 ± 10.04

0.27

Systolic pressure (mmHg)

131.05 ± 7.56

164.74 ± 18.26

0.31

Diastolic pressure (mmHg)

79.47 ± 6.64

116.26 ± 19.2.

0.26

Pulse rate (bpm)

70.94 ± 11.88

71.56 ± 6.97

0.86

Sexb

8 (male); 11 (female)

8 (male); 15 (female)

0.62

Concomitant age-related diseases different from AD

14 (yes); 4 (no)

14 (yes); 8 (no)

0.94

  1. aValues are expressed as means ± SD. bSex values are reported as absolute values.